Related Experiment Video
Updated: Jun 16, 2026
![Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F60445.jpg&w=3840&q=50)
04:12
Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)
Published on: December 19, 2019
FcRgamma activation regulates inflammation-associated squamous carcinogenesis
Pauline Andreu1, Magnus Johansson, Nesrine I Affara
1Department of Pathology, University of California, San Francisco, 94143, USA.
Cancer Cell
|February 9, 2010
Summary
B cells and autoantibodies promote cancer by activating myeloid cells via Fcgamma receptors (FcgammaRs) in premalignant tissues. This chronic inflammation drives cancer development, highlighting a novel pathway in carcinogenesis.
Area of Science:
- Immunology
- Oncology
- Dermatology
Background:
- Chronic inflammation in premalignant tissues influences cancer development.
- The precise roles of immune cells, particularly B cells, in tumor programming are not fully understood.
Purpose of the Study:
- To elucidate the mechanisms by which immune cells program neoplastic tissues, promoting or inhibiting cancer progression.
- To investigate the role of B cells and humoral immunity in squamous carcinogenesis.
Main Methods:
- Utilized the K14-HPV16 mouse model for studying squamous carcinogenesis.
- Analyzed the impact of B cells and autoantibodies on myeloid cell activation via Fcgamma receptors (FcgammaRs).
- Examined leukocyte recruitment, composition, and function within neoplastic tissue.
Main Results:
- B cells and humoral immunity were found to promote cancer development in the K14-HPV16 model.
- Activation of FcgammaRs on myeloid cells by autoantibodies in the stroma was identified as a key mechanism.
- This interaction regulated leukocyte dynamics and promoted neoplastic progression and carcinoma development.
Conclusions:
- A model is proposed where B cells, humoral immunity, and FcgammaR activation drive chronic inflammation that promotes de novo carcinogenesis.
- These findings identify a critical pathway involving immune cells in initiating and promoting squamous cell carcinoma.
Related Concept Videos
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:16TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
01:28Inflammatory Response
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
02:26NF-κB-dependent Signaling Pathway
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
01:25Mutagenicity and Carcinogenicity
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
01:01Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...